BMC Health Services Research

Fig. 1 | BMC Health Services Research

Fig. 1

From: Cost-utility analysis of palonosetron in the antiemetic regimen for cisplatin-containing highly emetogenic chemotherapy in Japan

Fig. 1

ISSN: 1472-6963

Contact us

Submission enquiries: bmchealthservicesresearch@biomedcentral.com
General enquiries: ORSupport@springernature.com